Science 37 Holdings (Science 37 Holdings) Gross Profit : $17.92 Mil (TTM As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Science 37 Holdings Gross Profit?

Science 37 Holdings's gross profit for the three months ended in Sep. 2023 was $5.92 Mil. Science 37 Holdings's gross profit for the trailing twelve months (TTM) ended in Sep. 2023 was $17.92 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Science 37 Holdings's gross profit for the three months ended in Sep. 2023 was $5.92 Mil. Science 37 Holdings's Revenue for the three months ended in Sep. 2023 was $14.89 Mil. Therefore, Science 37 Holdings's Gross Margin % for the quarter that ended in Sep. 2023 was 39.73%.

Science 37 Holdings had a gross margin of 39.73% for the quarter that ended in Sep. 2023 => Competition eroding margins

During the past 3 years, the highest Gross Margin % of Science 37 Holdings was 29.74%. The lowest was 22.62%. And the median was 22.62%.

Science 37 Holdings Gross Profit Historical Data

The historical data trend for Science 37 Holdings's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Science 37 Holdings Gross Profit Chart

Science 37 Holdings Annual Data

Trend

Jun20

Jun21

Dec22

Gross Profit

15.87

Science 37 Holdings Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Gross Profit	Get a 7-Day Free Trial									4.09	3.64	2.98	5.39	5.92

Competitive Comparison of Science 37 Holdings's Gross Profit

For the Health Information Services subindustry, Science 37 Holdings's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Science 37 Holdings's Gross Profit Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Science 37 Holdings's Gross Profit distribution charts can be found below:

* The bar in red indicates where Science 37 Holdings's Gross Profit falls into.

Science 37 Holdings Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Science 37 Holdings's Gross Profit for the fiscal year that ended in Dec. 2022 is calculated as

Gross Profit (A: Dec. 2022 )	=	Revenue	-	Cost of Goods Sold
	=	70.147	-	54.278
	=	15.87

Science 37 Holdings's Gross Profit for the quarter that ended in Sep. 2023 is calculated as

Gross Profit (Q: Sep. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	14.887	-	8.972
	=	5.92

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $17.92 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Science 37 Holdings's Gross Margin % for the quarter that ended in Sep. 2023 is calculated as

Gross Margin % (Q: Sep. 2023 )	=	Gross Profit (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	5.92	/	14.887
	=	39.73 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Science 37 Holdings (NAS:SNCE) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Science 37 Holdings had a gross margin of 39.73% for the quarter that ended in Sep. 2023 => Competition eroding margins

Science 37 Holdings Gross Profit Related Terms

Thank you for viewing the detailed overview of Science 37 Holdings's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Science 37 Holdings (Science 37 Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Science 37 Holdings Inc (NAS:SNCE) » Definitions » Gross Profit

Comparable Companies

Traded in Other Exchanges

N/A

Address

800 Park Offices Drive, Suite 3606, Research Triangle Park, Durham, NC, USA, 27709

Website

https://www.science37.com

Science 37 Holdings Inc is engaged in the development of new and innovative treatments that impact patient lives. It enables universal access to patients and providers for clinical trials. Its Operating System is fused with networks of telemedicine investigators, mobile nurses, remote coordinators, patient communities and connected devices.

Executives

Troy Bryenton	officer: Chief Technology Officer	800 PARK OFFICES DRIVE, SUITE 3606, RESEARCH TRIANGLE PARK NC 27709
Christine A Pellizzari	officer: Chief Legal Officer	10 FINDERNE AVENUE, BRIDGEWATER NJ 08807
Autenried Paul Von	director	BRISTOL-MYERS SQUIBB COMPANY, 100 NASSAU PARK BOULEVARD, PRINCETON NJ 08543
Michael Shipton	officer: Chief Commercial Officer	800 PARK OFFICES DRIVE SUITE 3606, RESEARCH TRIANGLE PARK NC 27709
Adam Goulburn	director	C/O LIFESCI ACQUISITION II CORP., 250 W 55TH STREET, #3401, NEW YORK NY 10019
Thermo Fisher Scientific Powder Us Holdings Corp.	10 percent owner	168 THIRD AVENUE, WALTHAM MA 02451
Thermo Fisher Scientific Inc.	10 percent owner	168 THIRD AVENUE, WALTHAM MA 02451
Neil Tiwari	director	C/O LIFESCI ACQUISITION II CORP., 250 W 55TH STREET, #3401, NEW YORK NY 10019
Darcy Forman	officer: Chief Delivery Officer	C/O LIFESCI ACQUISITION II CORP., 250 W 55TH STREET, #3401, NEW YORK NY 10019
David Coman	director, officer: Chief Executive Officer	C/O LIFESCI ACQUISITION II CORP., 250 W 55TH STREET, #3401, NEW YORK NY 10019
Jonathan Cotliar	officer: Chief Medical Officer	C/O LIFESCI ACQUISITION II CORP., 250 W 55TH STREET, #3401, NEW YORK NY 10019
Steven Geffon	officer: Chief Commercial Officer	C/O LIFESCI ACQUISITION II CORP., 250 W 55TH STREET, #3401, NEW YORK NY 10019
De Silva Bhooshitha B.	director	PPD, INC., 929 NORTH FRONT STREET, WILMINGTON NC 28401
Mike Zaranek	officer: Chief Financial Officer	C/O LIFESCI ACQUISITION II CORP., 250 W 55TH STREET, #3401, NEW YORK NY 10019
Ppd, Inc.	10 percent owner	929 NORTH FRONT STREET, WILMINGTON NC 28401-3331